CARGO Therapeutics (CRGX) Competitors $4.55 +0.09 (+2.02%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$4.49 -0.06 (-1.30%) As of 04/15/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRGX vs. NRIX, ZYME, GYRE, DAWN, AVXL, PHVS, XERS, NTLA, EOLS, and AVDLShould you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Nurix Therapeutics (NRIX), Zymeworks (ZYME), Gyre Therapeutics (GYRE), Day One Biopharmaceuticals (DAWN), Anavex Life Sciences (AVXL), Pharvaris (PHVS), Xeris Biopharma (XERS), Intellia Therapeutics (NTLA), Evolus (EOLS), and Avadel Pharmaceuticals (AVDL). These companies are all part of the "pharmaceutical products" industry. CARGO Therapeutics vs. Nurix Therapeutics Zymeworks Gyre Therapeutics Day One Biopharmaceuticals Anavex Life Sciences Pharvaris Xeris Biopharma Intellia Therapeutics Evolus Avadel Pharmaceuticals CARGO Therapeutics (NASDAQ:CRGX) and Nurix Therapeutics (NASDAQ:NRIX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, community ranking, institutional ownership, earnings and analyst recommendations. Does the media refer more to CRGX or NRIX? In the previous week, Nurix Therapeutics had 30 more articles in the media than CARGO Therapeutics. MarketBeat recorded 33 mentions for Nurix Therapeutics and 3 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 1.16 beat Nurix Therapeutics' score of 0.55 indicating that CARGO Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CARGO Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nurix Therapeutics 7 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 3 Negative mention(s) 2 Very Negative mention(s) Positive Is CRGX or NRIX more profitable? CARGO Therapeutics has a net margin of 0.00% compared to Nurix Therapeutics' net margin of -354.85%. CARGO Therapeutics' return on equity of -38.16% beat Nurix Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CARGO TherapeuticsN/A -38.16% -33.94% Nurix Therapeutics -354.85%-53.65%-38.59% Which has better valuation & earnings, CRGX or NRIX? CARGO Therapeutics has higher earnings, but lower revenue than Nurix Therapeutics. Nurix Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCARGO TherapeuticsN/AN/A-$98.15M-$3.72-1.21Nurix Therapeutics$56.42M13.27-$193.57M-$2.80-3.51 Do analysts recommend CRGX or NRIX? CARGO Therapeutics presently has a consensus price target of $15.00, indicating a potential upside of 232.59%. Nurix Therapeutics has a consensus price target of $30.44, indicating a potential upside of 210.02%. Given CARGO Therapeutics' higher possible upside, equities research analysts clearly believe CARGO Therapeutics is more favorable than Nurix Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86Nurix Therapeutics 0 Sell rating(s) 3 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.84 Does the MarketBeat Community prefer CRGX or NRIX? Nurix Therapeutics received 71 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. Likewise, 78.70% of users gave Nurix Therapeutics an outperform vote while only 66.67% of users gave CARGO Therapeutics an outperform vote. CompanyUnderperformOutperformCARGO TherapeuticsOutperform Votes1466.67% Underperform Votes733.33% Nurix TherapeuticsOutperform Votes8578.70% Underperform Votes2321.30% Do institutionals & insiders have more ownership in CRGX or NRIX? 93.2% of CARGO Therapeutics shares are owned by institutional investors. 1.4% of CARGO Therapeutics shares are owned by insiders. Comparatively, 7.2% of Nurix Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, CRGX or NRIX? CARGO Therapeutics has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500. Comparatively, Nurix Therapeutics has a beta of 2.23, meaning that its share price is 123% more volatile than the S&P 500. SummaryNurix Therapeutics beats CARGO Therapeutics on 9 of the 17 factors compared between the two stocks. Remove Ads Get CARGO Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRGX vs. The Competition Export to ExcelMetricCARGO TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$207.70M$2.89B$5.32B$7.56BDividend YieldN/A1.91%5.11%4.33%P/E Ratio-1.0630.8821.7717.81Price / SalesN/A435.82378.2693.59Price / CashN/A168.6838.1534.64Price / Book0.463.476.443.99Net Income-$98.15M-$72.06M$3.20B$247.23M7 Day Performance16.84%8.57%6.42%7.24%1 Month Performance7.13%-17.48%-8.66%-6.26%1 Year Performance-77.33%-29.58%10.27%-0.18% CARGO Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRGXCARGO Therapeutics2.8565 of 5 stars$4.55+2.0%$15.00+229.7%-77.1%$209.54MN/A-1.07116Positive NewsNRIXNurix Therapeutics2.1174 of 5 stars$9.72+0.3%$30.88+217.7%-36.5%$741.01M$54.55M-3.36300Gap DownHigh Trading VolumeZYMEZymeworks2.6506 of 5 stars$10.43-4.7%$21.00+101.3%+20.4%$725.69M$76.30M-6.95460Positive NewsGYREGyre Therapeutics0.1333 of 5 stars$7.62+10.1%N/A-49.0%$713.32M$105.76M152.4040Short Interest ↑High Trading VolumeDAWNDay One Biopharmaceuticals2.4554 of 5 stars$7.02-2.8%$32.29+359.9%-48.1%$711.51M$131.16M-6.8260Gap DownAVXLAnavex Life Sciences3.5111 of 5 stars$8.33+1.7%$44.00+428.2%+115.6%$708.58MN/A-15.1540Positive NewsPHVSPharvaris1.4049 of 5 stars$13.21-7.5%$40.50+206.6%-30.8%$690.75MN/A-4.7230XERSXeris Biopharma4.319 of 5 stars$4.41flat$6.10+38.3%+136.8%$678.88M$203.07M-9.80290Short Interest ↑News CoveragePositive NewsGap DownHigh Trading VolumeNTLAIntellia Therapeutics4.3268 of 5 stars$6.54-1.4%$37.56+474.2%-67.9%$677.00M$57.88M-1.20600Gap DownHigh Trading VolumeEOLSEvolus3.4956 of 5 stars$10.24-4.2%$24.67+140.9%-14.0%$651.13M$266.27M-11.25170Analyst RevisionPositive NewsGap DownAVDLAvadel Pharmaceuticals2.2544 of 5 stars$6.69-1.6%$19.88+197.1%N/A$646.45M$169.12M-8.4770Analyst RevisionNews CoverageGap Down Remove Ads Related Companies and Tools Related Companies NRIX Competitors ZYME Competitors GYRE Competitors DAWN Competitors AVXL Competitors PHVS Competitors XERS Competitors NTLA Competitors EOLS Competitors AVDL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRGX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.